These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31626220)

  • 1. [Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period].
    Mashin VV; Belova LA; Aizatullin IF; Pavlova VA; Slasten EV; Abramova VV; Belov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):62-67. PubMed ID: 31626220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of Korteksin in acute period of hemispheric ischemic stroke].
    Belova LA; Mashin VV; Abramova VV; Slastyon EY; Belov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(7):30-34. PubMed ID: 30132453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of cortexin in acute and recovery periodes of hemispheric ischemic stroke].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsjannikova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):38-42. PubMed ID: 27845314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the efficacy of Cellex and Cortexin in patients in the early recovery period of ischemic stroke].
    Khabirov FA; Khaibullin TI; Granatov EV; Akhmetova GI; Akhmetzyanov NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):11-15. PubMed ID: 33449527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cognitive impairment in patients poluchennym ischemic stroke in the acute and early recovery periods in the process of neuroprotection low-dose drug cortexin].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsjannikova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8 Pt 2):40-43. PubMed ID: 27905386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke].
    Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EFFECT OF CORTEXIN ON THE QUALITY OF LIFE IN THE EARLY REHABILITATIVE PERIOD AFTER HEMISPHERIC ISCHEMIC STROKE].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsyannikova AN
    Klin Med (Mosk); 2016; 94(2):138-43. PubMed ID: 27459764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity].
    Nurguzhaev ES; Mitrokhin DA; Izbasarova ASh; Nurguzhaev AE; Raimkulov BN; Abdil'manova BR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):66-9. PubMed ID: 19672239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The experience of using cellex in treatment of patients with acute ischemic stroke].
    Gaponenko IA; Bakhareva EV; Zolotareva ZM; Zuev GI; Rozhdestvenskiy AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):43-47. PubMed ID: 29863691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy and pharmacoeconomic characteristics of the neuroprotection with low doses of cortexin in the treatment of acute ischemic stroke].
    Aliferova VM; Dadasheva MN; Doronin BM; Kovalenko AV; Lokshtanova TM; Martynov MIu; Meshkova KS; Salimov KA; Stakhovskaia LV; Chefranova ZhIu; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):41-6. PubMed ID: 24874316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of the efficacy and safety of L-carnitine in patients with ischemic stroke in the early rehabilitation period].
    Chichanovskaya LV; Bakhareva ON; Sorokina KB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):65-69. PubMed ID: 29411748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)].
    Fedin AI; Belskaya GN; Kurushina OV; Kovalchuk VV; Starych EV; Chichanovskaya LV; Baranova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):35-42. PubMed ID: 30335070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
    Cho HJ; Kim YJ
    Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of neuropeptides in cerebrovascular pathology].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):88-93. PubMed ID: 28635743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New possibilities of neuroprotection in the treatment of ischemic stroke].
    Skoromets AA; Stakhovskaia LV; Belkin AA; Shekhovtsova KV; Kerbikov OB; Burenchev DV; Gavrilova OV; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():32-8. PubMed ID: 19431244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
    Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
    Strelnikova IA; Svetkina AA; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
    Loskutnikov MA; Domashenko MA; Vakin TM; Trushina IA; Konstantinov VI; Proskuryakova OS; Shchukina EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):22-26. PubMed ID: 33244953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of the anti-acidemic agent dimephosphone at the first rehabilitation stage in patients in the acute period of carotid-related ischemic stroke].
    Danilova TV; Knni KS; Magsumova RL; Baranova EA; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):44-51. PubMed ID: 33834717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.